Sale!

CanAssist Breast Cancer Prognostic Test

Original price was: R28,200.Current price is: R25,350.

-10%

The CanAssist Breast Test provides personalised prognosis for breast cancer patients in South Africa, helping you and your oncologist make informed treatment decisions. This advanced test analyses your specific tumour characteristics to determine your risk of recurrence, giving you clarity and confidence in your treatment journey. For just ZAR 25,350 (regularly ZAR 28,200), you gain access to crucial information that could guide whether chemotherapy is necessary for your specific case. Available nationwide including Johannesburg, Cape Town, Durban and Pretoria, this test brings cutting-edge cancer care directly to South African patients. With results in just 15 working days and sample collection available daily until 3:30 PM, you can take control of your breast cancer journey with trusted, accurate medical insights from Oracle Genomics.

📞 24/7 South African Support Team Call : +27 6412 56421

  • ✓ ISO Accredited Lab Reports
  • ✓ Free Genetic Counseling Included
  • 🔒 100% Confidential & Secure Testing
Guaranteed Safe Checkout

CanAssist Breast Test ZAR 25
CanAssist Breast Cancer Prognostic Test
R28,200 Original price was: R28,200.R25,350Current price is: R25,350.

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Take Control of Your Breast Cancer Journey with Personalised Prognosis

Facing a breast cancer diagnosis can feel overwhelming, especially when making critical treatment decisions. The CanAssist Breast Test provides the clarity and confidence you need during this challenging time. We understand the anxiety that comes with uncertainty about recurrence risk and treatment options. That’s why we’ve made this advanced prognostic testing accessible to South African patients across Johannesburg, Cape Town, Durban, and Pretoria.

Understanding Your CanAssist Breast Test

The CanAssist Breast Test is a sophisticated prognostic tool specifically designed for patients with ER-positive, PR-positive, and HER2-negative breast cancer. Using advanced immunohistochemistry technology, this test analyses five key protein biomarkers in your tumour tissue to provide a personalised recurrence risk score. Think of it as your personalised roadmap through breast cancer treatment – helping you and your oncologist determine whether chemotherapy would provide significant benefit for your specific cancer profile.

Who Should Consider This Test?

If you’ve been diagnosed with early-stage breast cancer that is hormone receptor-positive (ER+ and PR+) but HER2-negative, this test could be crucial for your treatment planning. Many patients face the difficult decision about whether to undergo chemotherapy, and this test provides the scientific evidence to guide that choice. Your peace of mind matters, and having clear, personalised information can significantly reduce the stress of treatment decisions.

Why This Matters for Your Health Journey

Getting the right treatment at the right time is essential for breast cancer recovery. The CanAssist Breast Test helps prevent both overtreatment and undertreatment by providing a clear risk assessment. Patients who receive a low-risk score may avoid unnecessary chemotherapy and its associated side effects, while those with high-risk scores can proceed with confidence knowing chemotherapy is the right choice. This personalised approach represents the future of cancer care, now available to South African patients.

Understanding Your Results with Confidence

Your test results will provide a clear risk score that categorises your recurrence risk as either low or high. Our medical team ensures you understand exactly what your results mean for your treatment journey. We provide comprehensive support and guidance, helping you discuss the findings with your oncologist to make the best decisions for your health. Remember, knowledge is power – and having this information puts you in control of your cancer journey.

Transparent Pricing – Investing in Your Health

Service Regular Price Special Price
CanAssist Breast Test ZAR 28,200 ZAR 25,350

Consider this an investment in your peace of mind and personalised treatment planning. The cost of unnecessary chemotherapy and its side effects far exceeds this test price, making it a valuable decision for both your health and financial wellbeing.

Why Trust Oracle Genomics?

With nationwide coverage across South Africa’s major cities including Johannesburg, Cape Town, Durban, and Pretoria, we bring world-class cancer diagnostics to your doorstep. Our partnership with leading oncologists ensures you receive the highest standard of care. The test requires only a formalin-fixed paraffin-embedded tissue block from your previous biopsy, making the process straightforward and minimally invasive.

Key Service Details:
• Turnaround Time: 15 working days
• Sample Collection: Daily until 3:30 PM
• Required: Completed CanAssist-Breast Test Requisition Form (Form 41)
• Sample: Formalin fixed paraffin embedded tissue block

Take the Next Step in Your Cancer Journey

Don’t let uncertainty dictate your treatment decisions. The CanAssist Breast Test provides the clarity you need to move forward with confidence. Contact us today to schedule your test or speak with our medical team about whether this test is right for your situation. Early, informed decisions can make all the difference in your recovery journey.

Book Your Test Today: Available nationwide with convenient sample collection and clear, supportive guidance throughout the process.